Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Neubase Therapeutics Inc. buy elfe

Neubase Therapeutics Inc.
Start price
€2,596.8
31.01.15 / 50%
Target price
€4,800.0
01.06.15
Performance (%)
-64.20%
End price
€929.60
01.06.15
Summary
This prediction ended on 01.06.15 with a price of €929.60. Massive losses of -64.20% were the result for the BUY prediction by elfe. elfe has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Neubase Therapeutics Inc. - - - -
iShares Core DAX® 0.437% 5.897% 8.047% 65.579%
iShares Nasdaq 100 1.057% 0.920% 28.466% 90.185%
iShares Nikkei 225® 1.769% 1.228% 47.574% 84.991%
iShares S&P 500 0.368% 1.920% 23.200% 70.760%

Comments by elfe for this prediction

In the thread NeuBase Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) -64.20%
Target price 240.000
Change
Ends at 01.06.15

Neue Wege und klare Lösungen, Ohr Pharmaceutical auf dem weg neuartige Therapien zu finden.

Marktplazierung: 172,85 Millionen Euro

Anzahl der Aktien: 25,39 Millionen

Kaufsignal

elfe 
0
Report Share
31.01.15
Prediction Buy
Perf. (%) -64.20%
Target price 240.000
Change
Ends at 01.06.15

(Vom Mitglied beendet)

elfe 
0
Report Share
01.06.15